Cargando…
PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway
Procollagen‐lysine, 2‐oxoglutarate 5‐dioxygenase 2 (PLOD2) has been reported as an oncogenic gene, affecting various malignant tumors, including endometrial carcinoma, osteosarcoma, and gastric cancer. These effects are mostly due to the enhanced deposition of collagen precursors. However, more stud...
Autores principales: | Lan, Jiawen, Zhang, Sijing, Zheng, Lin, Long, Xiaoli, Chen, Jianxiong, Liu, Xunhua, Zhou, Miao, Zhou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394153/ https://www.ncbi.nlm.nih.gov/pubmed/37227305 http://dx.doi.org/10.1111/cas.15851 |
Ejemplares similares
-
RSL1D1 promotes the progression of colorectal cancer through RAN-mediated autophagy suppression
por: Liu, Xunhua, et al.
Publicado: (2022) -
LARP6 suppresses colorectal cancer progression through ZNF267/SGMS2-mediated imbalance of sphingomyelin synthesis
por: Long, Xiaoli, et al.
Publicado: (2023) -
The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling
por: Zhang, Ruohan, et al.
Publicado: (2022) -
CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways
por: Chen, Lixia, et al.
Publicado: (2020) -
PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)